EP2830642
SUBCUTANEOUS ADMINISTRATION OF IDURONATE- 2-SULFATASE
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
14.3.2013EP published:
28.8.2019EP application number:
13769624.1
EPO information:
European Patent Register
Max expiry date:
13.3.2033
Title:
SUBCUTANEOUS ADMINISTRATION OF IDURONATE- 2-SULFATASE
Timeline
Today
14.3.2013EP application
28.8.2019EP Publication
Owner
Name:
Shire Human Genetic Therapies, Inc.Address:
300 Shire Way, 02421, Lexington MA, US
Inventor
Name:
XIE, HongshengAddress:
Acton, MA, US
Name:
FELICE, BrianAddress:
Wellesley, MA, US
Name:
MCCAULEY, ThomasAddress:
Cambridge, MA, US
Priority
Number:
201261618638 PDate:
30.3.2012Country:
US
Classification
Categories:
A61K 38/00, A61K 38/43, A61P 25/00